Q/C Technologies, Inc. Available-for-sale Securities, Gross Unrealized Loss
Q/C Technologies, Inc. (QCLS) reported Available-for-sale Securities, Gross Unrealized Loss of $16.84 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-07-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss · last filed 2018-07-13
- Q/C Technologies, Inc. available-for-sale securities, gross unrealized loss for the quarter ending 2018-03-31 was $16.84K.
- Q/C Technologies, Inc. available-for-sale securities, gross unrealized loss for the quarter ending 2016-09-30 was $1.47K.
- Q/C Technologies, Inc. available-for-sale securities, gross unrealized loss for the quarter ending 2016-06-30 was $383.00, a 92.55% decline year-over-year.
- Q/C Technologies, Inc. available-for-sale securities, gross unrealized loss for the quarter ending 2016-03-31 was $707.00, a 77.68% decline year-over-year.
- Q/C Technologies, Inc. available-for-sale securities, gross unrealized loss for fiscal 2015 was $6.23K, a 69.04% decline from fiscal 2014.
- Q/C Technologies, Inc. available-for-sale securities, gross unrealized loss for fiscal 2014 was $20.12K.
| Period end | Available-for-sale Securities, Gross Unrealized Loss 3 month | Available-for-sale Securities, Gross Unrealized Loss 6 month | Available-for-sale Securities, Gross Unrealized Loss 9 month | Available-for-sale Securities, Gross Unrealized Loss 12 month |
|---|---|---|---|---|
| 2018-03-31 | $16.84K 10-Q · filed 2018-07-13 | |||
| 2016-09-30 | $1.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $1.85K derived: sum of 2 quarters · filed 2016-11-14 | $2.56K 10-Q · filed 2016-11-14 | $7.57K derived: sum of 4 quarters · filed 2017-04-11 |
| 2016-06-30 | $383.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $1.09K 10-Q · filed 2016-08-11 | $6.10K derived: sum of 3 quarters · filed 2017-04-11 | -$989.00 derived: sum of 4 quarters · filed 2017-04-11 |
| 2016-03-31 | $707.00 10-Q · filed 2016-05-12 | $5.71K derived: sum of 2 quarters · filed 2017-04-11 | -$1.37K derived: sum of 3 quarters · filed 2017-04-11 | $3.77K derived: sum of 4 quarters · filed 2017-04-11 |
| 2015-12-31 | $5.01K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-11 | -$2.08K derived: sum of 2 quarters · filed 2017-04-11 | $3.06K derived: sum of 3 quarters · filed 2017-04-11 | $6.23K 10-K · filed 2017-04-11 |
| 2015-09-30 | -$7.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$1.94K derived: sum of 2 quarters · filed 2015-11-13 | $1.23K 10-Q · filed 2015-11-13 | $6.48K derived: sum of 4 quarters · filed 2016-03-30 |
| 2015-06-30 | $5.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-18 | $8.31K 10-Q · filed 2015-08-18 | $13.56K derived: sum of 3 quarters · filed 2016-03-30 | $24.55K derived: sum of 4 quarters · filed 2016-03-30 |
| 2015-03-31 | $3.17K 10-Q · filed 2015-05-14 | $8.42K derived: sum of 2 quarters · filed 2016-03-30 | $19.40K derived: sum of 3 quarters · filed 2016-03-30 | $11.88K derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-12-31 | $5.25K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $16.23K derived: sum of 2 quarters · filed 2016-03-30 | $8.72K derived: sum of 3 quarters · filed 2016-03-30 | $20.12K 10-K · filed 2016-03-30 |
| 2014-09-30 | $10.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $3.46K derived: sum of 2 quarters · filed 2014-11-13 | $14.87K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | -$7.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $3.89K 10-Q · filed 2014-08-12 | ||
| 2014-03-31 | $11.41K 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |